Cooperating G6PD mutations associated with severe neonatal hyperbilirubinemia and cholestasis

Pediatr Blood Cancer. 2011 May;56(5):840-2. doi: 10.1002/pbc.22744. Epub 2010 Oct 14.

Abstract

We report a novel glucose-6-phosphate dehydrogenase (G6PD) mutation, which we propose to name G6PD Cincinnati (c.1037A > T, p.N346I), found in combination with G6PD Gastonia (c.637G > T, p.V213L) in an infant who presented with neonatal cholestasis. The G6PD Cincinnati mutation results in a non-conservative amino acid substitution at the tetramer interface disturbing its formation, as seen by native gel electrophoresis and immunoblotting. G6PD Gastonia disrupts dimerization of the enzyme and by itself causes chronic non-spherocytic hemolytic anemia. The G6PD Cincinnati mutation may have aggravated the clinical picture of G6PD Gastonia with the result of severe perinatal hemolysis causing cholestasis and associated liver injury.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acid Sequence
  • Amino Acid Substitution
  • Cholestasis / enzymology
  • Cholestasis / etiology*
  • Cholestasis / pathology
  • DNA / genetics
  • Glucosephosphate Dehydrogenase / genetics*
  • Glucosephosphate Dehydrogenase Deficiency / enzymology
  • Glucosephosphate Dehydrogenase Deficiency / genetics*
  • Humans
  • Hyperbilirubinemia, Neonatal / enzymology
  • Hyperbilirubinemia, Neonatal / etiology*
  • Hyperbilirubinemia, Neonatal / pathology
  • Infant, Newborn
  • Male
  • Molecular Sequence Data
  • Mutation / genetics*
  • Polymerase Chain Reaction
  • Sequence Homology, Amino Acid

Substances

  • DNA
  • Glucosephosphate Dehydrogenase